You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Envista Holdings Corporation filed an automatic shelf registration for an indeterminate amount of multiple securities, enabling offerings from time to time through agents, underwriters, dealers or direct sales.
Invista Holdings Corporation raised its 2026 guidance for core sales growth to 3.75% to 4.25%, adjusted EBITDA growth to 12.5% to 14%, and adjusted EPS to $1.54 to $1.58, after Q3 adjusted EBITDA grew 9%.
Envista reported third-quarter adjusted diluted EPS of $0.40, up 25% year-over-year, and raised 2026 adjusted diluted EPS guidance to $1.54 to $1.58. Adjusted EBITDA growth guidance increased to 12.5% to 14%.
Envista released its 2025 Sustainability Report on October 27, 2026, citing a 40% waste reduction, 19% lower water consumption, $2.4 million for patient care benefiting close to 20,000 patients, and a 17% decline in lost time injury rate.
Useful current figures from the complete screener profile.
* Q4 derived as the full year minus Q1 to Q3.
TL;DR. Envista delivered 2.7% core sales growth, 25% adjusted EPS growth and margin expansion, then raised full-year core sales, EBITDA and EPS guidance; Versa growth and profitability were ahead of plan and the company repurchased approximately $10 million of stock. The main risks are double-digit China contraction and China VBP-related revenue and margin pressure, soft U.S. demand, slightly negative implied Q4 core growth, and lower year-over-year free cash flow.
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Still-open targets the latest release did not restate under the same label.
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Illustrative technical + ownership context — a signal mix, not investment advice.
| Metric | Latest | Period | YoY |
|---|---|---|---|
| Adjusted EBITDA non-GAAP | $207M | Six Months Ended July 3, 2026 | — |
| Adjusted EBITDA margin non-GAAP | 14.7% | Q2 2026 | — |
| Amount spent on stock repurchases | $58.6M | the three months ended July 3, 2026 filing | — |
| Core Sales Growth non-GAAP | 7.1% | Six Month Period Ended July 3, 2026 vs. Comparable 2025 Period | — |
|
|
|||
| Equipment & Consumables Core Sales Growth non-GAAP | 8.5% | Three Month Period Ended July 3, 2026 vs. Comparable 2025 Period | — |
| FCF to Adjusted Net Income Conversion Ratio non-GAAP | 158% | Three Months Ended July 3, 2026 | — |
| Free cash flow non-GAAP | $105M | Q2 2026 | — |
GAAP → non-GAAP reconciliationGAAP Net operating cash (used in) provided by operating activities $119.2M
-$14.9M Payments for additions to property, plant and equipment (capital expenditures)
+$0.8M Proceeds from sales of property, plant and equipment
= Free Cash Flow $105.1M
|
|||
| IEEPA tariff refunds received | $12.6M | second quarter of 2026 filing | — |
| International sales as percentage of total sales | 54.5% | three months ended July 3, 2026 filing | — |
| Operating cash flow | $119M | Q2 2026 | — |
| Operating profit margin | 17.7% | the three months ended July 3, 2026 filing | — |
| Remaining repurchase capacity | $283M | As of end of Q2 2026 | — |
| Sales growth | 9.5% | the three months ended July 3, 2026 filing | — |
| Shares repurchased | 2.4M | Q2 2026 | — |
| Total sales growth (GAAP) | 7.1% | three months ended July 3, 2026 filing | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
NVST
this stock
Envista Holdings Corp
|
$3.93B | +12.8% | -0.1% | 6.3 | 6.1% |
|
ISRG
Intuitive Surgical Inc
|
$153.77B | -21.7% | +20.5% | 53.8 | 2.0% |
|
BDX
Becton Dickinson & Co
|
$59.39B | — | +8.2% | 96.5 | 3.0% |
|
MDLN
Medline Inc.
|
$51.92B | -6.0% | +11.5% | — | 2.9% |
|
ALC
Alcon Inc
|
$35.61B | -6.0% | +10.5% | — | 3.8% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
Envista Holdings Corporation filed an automatic shelf registration for an indeterminate amount of multiple securities, enabling offerings from time to time through agents, underwriters, dealers or direct sales.
View| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| NVST | -2.7% | +6.9% | +4.2% | +4.2% | +12.8% |
| SPY | +2.6% | -1.2% | +0.5% | -0.2% | +10.6% |
| vs SPY | -5.3% | +8.1% | +3.7% | +4.4% | +2.2% |
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.
